Stephen Saad, Aspen Pharmacare CEO
August 11, 2022 09:59 AM EDT
Coronavirus
Manufacturing

De­mand-con­strained Covid vac­cine mar­ket may push South Africa's As­pen to change its di­rec­tion

Tyler Patchen

News Reporter

Last year, South African man­u­fac­tur­er As­pen Phar­ma­care was in a good po­si­tion, as the com­pa­ny opened new man­u­fac­tur­ing lines and start­ed to pump out …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times